DOI: 10.1093/annonc/mdf174. Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors

Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors

10.1093/annonc/mdf174

Crossref journal-article

Elsevier BV

Annals of Oncology (78)

Bibliography

Sessa, C., Cuvier, C., Caldiera, S., Bauer, J., Van den Bosch, S., Monnerat, C., Semiond, D., PÃ©rard, D., Lebecq, A., Besenval, M., & Marty, M. (2002). Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors. Annals of Oncology, 13(7), 1140â1150.

Authors 11

C. Sessa (first)
C. Cuvier (additional)
S. Caldiera (additional)
J. Bauer (additional)
S. Van den Bosch (additional)
C. Monnerat (additional)
D. Semiond (additional)
D. Pérard (additional)
A. Lebecq (additional)
M. Besenval (additional)
M. Marty (additional)

References 14 Referenced 36

{'key': '10.1093/annonc/mdf174_bb0010', 'series-title': 'RPR 109881A: Investigator’s brochure', 'author': 'Rorer', 'year': '1999'} / RPR 109881A: Investigator’s brochure by Rorer (1999)
{'key': '10.1093/annonc/mdf174_bb0015', 'article-title': 'A Phase I and pharmacokinetic (PK) study of RPR 109881A given as a 6-hour IV infusion in patients (pts) with advanced solid tumors', 'author': 'Barthier', 'year': '1998', 'journal-title': 'Proc Am Soc Clin Oncol'} / Proc Am Soc Clin Oncol / A Phase I and pharmacokinetic (PK) study of RPR 109881A given as a 6-hour IV infusion in patients (pts) with advanced solid tumors by Barthier (1998)
{'key': '10.1093/annonc/mdf174_bb0020', 'article-title': 'Phase I trial of RPR 109881A (RPR) a new taxoid derivative administered as a 24 hour continuous infusion', 'author': 'Slaughter', 'year': '1998', 'journal-title': 'Proc Am Soc Clin Oncol'} / Proc Am Soc Clin Oncol / Phase I trial of RPR 109881A (RPR) a new taxoid derivative administered as a 24 hour continuous infusion by Slaughter (1998)
10.1200/JCO.2000.18.24.4098 / J Clin Oncol / Phase I dose finding study of a new taxane, RPR 109881A, administered as a 1-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors by Gelmon (2000)
10.2307/2531628 / Biometrics / Continual reassessment method: a practical design for phase I clinical trials in cancer by O’Quigley (1990)
10.1080/10543409408835079 / J Biopharm Stat / Practical modifications of the continual reassessment method for Phase I cancer clinical trials by Faries (1994)
10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6 / Cancer / Reporting results of cancer treatment by Miller (1981)
10.1200/JCO.2000.18.17.3164 / J Clin Oncol / Phase I and pharmacokinetic study of a new taxoid, RPR 109881A, given as a 1-hour intravenous infusion in patients with advanced solid tumors by Kurata (2000)
{'key': '10.1093/annonc/mdf174_bb0050', 'article-title': 'Preliminary evaluation of the modified continual reassessment method (MCRM) in four Phase I studies of RPR 109881A', 'author': 'Lebecq', 'year': '1998', 'journal-title': 'Proc Am Soc Clin Oncol'} / Proc Am Soc Clin Oncol / Preliminary evaluation of the modified continual reassessment method (MCRM) in four Phase I studies of RPR 109881A by Lebecq (1998)
10.1007/s002800050032 / Cancer Chemother Pharmacol / Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion by Rosing (2000)
{'key': '10.1093/annonc/mdf174_bb0060', 'first-page': '599', 'article-title': 'Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-h infusion', 'volume': '1', 'author': 'Ohtsu', 'year': '1995', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-h infusion by Ohtsu (1995)
10.1200/JCO.1995.13.1.180 / J Clin Oncol / Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans by Gianni (1995)
10.1200/JCO.1993.11.11.2127 / J Clin Oncol / Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients by Huizing (1993)
{'key': '10.1093/annonc/mdf174_bb0075', 'first-page': '1037', 'article-title': 'Phase I and pharmacokinetic study of Taxotere given as a short intravenous infusion', 'volume': '53', 'author': 'Extra', 'year': '1993', 'journal-title': 'Cancer Res'} / Cancer Res / Phase I and pharmacokinetic study of Taxotere given as a short intravenous infusion by Extra (1993)

Dates

Type	When
Created	23 years, 1 month ago (July 28, 2002, 6:39 p.m.)
Deposited	5 years, 6 months ago (Feb. 20, 2020, 2:35 a.m.)
Indexed	1 year, 10 months ago (Oct. 16, 2023, 12:56 p.m.)
Issued	23 years, 2 months ago (July 1, 2002)
Published	23 years, 2 months ago (July 1, 2002)
Published Print	23 years, 2 months ago (July 1, 2002)

Funders 0

None

BibTeX

@article{Sessa_2002, title={Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors}, volume={13}, ISSN={0923-7534}, url={http://dx.doi.org/10.1093/annonc/mdf174}, DOI={10.1093/annonc/mdf174}, number={7}, journal={Annals of Oncology}, publisher={Elsevier BV}, author={Sessa, C. and Cuvier, C. and Caldiera, S. and Bauer, J. and Van den Bosch, S. and Monnerat, C. and Semiond, D. and Pérard, D. and Lebecq, A. and Besenval, M. and Marty, M.}, year={2002}, month=jul, pages={1140–1150} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2023,
        10,
        16
      ]
    ],
    "date-time": "2023-10-16T16:56:53Z",
    "timestamp": 1697475413704
  },
  "reference-count": 14,
  "publisher": "Elsevier BV",
  "issue": "7",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2002,
            7,
            1
          ]
        ],
        "date-time": "2002-07-01T00:00:00Z",
        "timestamp": 1025481600000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    },
    {
      "start": {
        "date-parts": [
          [
            2020,
            1,
            7
          ]
        ],
        "date-time": "2020-01-07T00:00:00Z",
        "timestamp": 1578355200000
      },
      "content-version": "vor",
      "delay-in-days": 6399,
      "URL": "http://www.elsevier.com/open-access/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2002,
        7
      ]
    ]
  },
  "DOI": "10.1093/annonc/mdf174",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        7,
        28
      ]
    ],
    "date-time": "2002-07-28T22:39:17Z",
    "timestamp": 1027895957000
  },
  "page": "1140-1150",
  "source": "Crossref",
  "is-referenced-by-count": 36,
  "title": "Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors",
  "prefix": "10.1016",
  "volume": "13",
  "author": [
    {
      "given": "C.",
      "family": "Sessa",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "C.",
      "family": "Cuvier",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "S.",
      "family": "Caldiera",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "J.",
      "family": "Bauer",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "S.",
      "family": "Van den Bosch",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "C.",
      "family": "Monnerat",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "D.",
      "family": "Semiond",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "D.",
      "family": "P\u00e9rard",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "A.",
      "family": "Lebecq",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "M.",
      "family": "Besenval",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "M.",
      "family": "Marty",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1093/annonc/mdf174_bb0010",
      "series-title": "RPR 109881A: Investigator\u2019s brochure",
      "author": "Rorer",
      "year": "1999"
    },
    {
      "key": "10.1093/annonc/mdf174_bb0015",
      "article-title": "A Phase I and pharmacokinetic (PK) study of RPR 109881A given as a 6-hour IV infusion in patients (pts) with advanced solid tumors",
      "author": "Barthier",
      "year": "1998",
      "journal-title": "Proc Am Soc Clin Oncol"
    },
    {
      "key": "10.1093/annonc/mdf174_bb0020",
      "article-title": "Phase I trial of RPR 109881A (RPR) a new taxoid derivative administered as a 24 hour continuous infusion",
      "author": "Slaughter",
      "year": "1998",
      "journal-title": "Proc Am Soc Clin Oncol"
    },
    {
      "key": "10.1093/annonc/mdf174_bb0025",
      "doi-asserted-by": "crossref",
      "first-page": "4098",
      "DOI": "10.1200/JCO.2000.18.24.4098",
      "article-title": "Phase I dose finding study of a new taxane, RPR 109881A, administered as a 1-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors",
      "volume": "18",
      "author": "Gelmon",
      "year": "2000",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "10.1093/annonc/mdf174_bb0030",
      "doi-asserted-by": "crossref",
      "first-page": "33",
      "DOI": "10.2307/2531628",
      "article-title": "Continual reassessment method: a practical design for phase I clinical trials in cancer",
      "volume": "46",
      "author": "O\u2019Quigley",
      "year": "1990",
      "journal-title": "Biometrics"
    },
    {
      "key": "10.1093/annonc/mdf174_bb0035",
      "doi-asserted-by": "crossref",
      "first-page": "147",
      "DOI": "10.1080/10543409408835079",
      "article-title": "Practical modifications of the continual reassessment method for Phase I cancer clinical trials",
      "volume": "4",
      "author": "Faries",
      "year": "1994",
      "journal-title": "J Biopharm Stat"
    },
    {
      "key": "10.1093/annonc/mdf174_bb0040",
      "doi-asserted-by": "crossref",
      "first-page": "207",
      "DOI": "10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6",
      "article-title": "Reporting results of cancer treatment",
      "volume": "47",
      "author": "Miller",
      "year": "1981",
      "journal-title": "Cancer"
    },
    {
      "key": "10.1093/annonc/mdf174_bb0045",
      "doi-asserted-by": "crossref",
      "first-page": "3164",
      "DOI": "10.1200/JCO.2000.18.17.3164",
      "article-title": "Phase I and pharmacokinetic study of a new taxoid, RPR 109881A, given as a 1-hour intravenous infusion in patients with advanced solid tumors",
      "volume": "18",
      "author": "Kurata",
      "year": "2000",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "10.1093/annonc/mdf174_bb0050",
      "article-title": "Preliminary evaluation of the modified continual reassessment method (MCRM) in four Phase I studies of RPR 109881A",
      "author": "Lebecq",
      "year": "1998",
      "journal-title": "Proc Am Soc Clin Oncol"
    },
    {
      "key": "10.1093/annonc/mdf174_bb0055",
      "doi-asserted-by": "crossref",
      "first-page": "213",
      "DOI": "10.1007/s002800050032",
      "article-title": "Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion",
      "volume": "45",
      "author": "Rosing",
      "year": "2000",
      "journal-title": "Cancer Chemother Pharmacol"
    },
    {
      "key": "10.1093/annonc/mdf174_bb0060",
      "first-page": "599",
      "article-title": "Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-h infusion",
      "volume": "1",
      "author": "Ohtsu",
      "year": "1995",
      "journal-title": "Clin Cancer Res"
    },
    {
      "key": "10.1093/annonc/mdf174_bb0065",
      "doi-asserted-by": "crossref",
      "first-page": "180",
      "DOI": "10.1200/JCO.1995.13.1.180",
      "article-title": "Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans",
      "volume": "13",
      "author": "Gianni",
      "year": "1995",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "10.1093/annonc/mdf174_bb0070",
      "doi-asserted-by": "crossref",
      "first-page": "2127",
      "DOI": "10.1200/JCO.1993.11.11.2127",
      "article-title": "Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients",
      "volume": "11",
      "author": "Huizing",
      "year": "1993",
      "journal-title": "J Clin Oncol"
    },
    {
      "key": "10.1093/annonc/mdf174_bb0075",
      "first-page": "1037",
      "article-title": "Phase I and pharmacokinetic study of Taxotere given as a short intravenous infusion",
      "volume": "53",
      "author": "Extra",
      "year": "1993",
      "journal-title": "Cancer Res"
    }
  ],
  "container-title": "Annals of Oncology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0923753419638652?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0923753419638652?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://academic.oup.com/annonc/article-pdf/13/7/1140/437321/mdf174.pdf",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2020,
        2,
        20
      ]
    ],
    "date-time": "2020-02-20T07:35:54Z",
    "timestamp": 1582184154000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0923753419638652"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2002,
        7
      ]
    ]
  },
  "references-count": 14,
  "journal-issue": {
    "issue": "7",
    "published-print": {
      "date-parts": [
        [
          2002,
          7
        ]
      ]
    }
  },
  "alternative-id": [
    "S0923753419638652"
  ],
  "URL": "http://dx.doi.org/10.1093/annonc/mdf174",
  "relation": {},
  "ISSN": [
    "0923-7534"
  ],
  "subject": [],
  "container-title-short": "Annals of Oncology",
  "published": {
    "date-parts": [
      [
        2002,
        7
      ]
    ]
  }
}